. 2009 Aug 10;2009:105376. doi: 10.1155/2009/105376

Table 3.

Post-hoc Analysis of Patients with Documented Incident Infection—Results from the First Treatment Period.

	HSV-2 Antibody	HSV-2 Antibody
	Negative ^a n = 4	Positive n = 31
Percent days with total shedding, Mean (SD %) P-value^b	43.8 (18.6 )	11.2 (14.8)
Percent days with total shedding, Mean (SD %) P-value^b	P < .001	11.2 (14.8)


Percent days with subclinical shedding, Mean (SD %) P-value^b	31.9 (12.8 )	8.9 (14.1)
	P = .002	8.9 (14.1)


Proportion of subjects recurrence-free^c, n (%)	0 (0)	19 (61)

^aThis group includes 3 subjects who were HSV-1 and HSV-2 seronegative, and one subject who was HSV-1 seropositive and HSV-2 seronegative.

^bThis was an exploratory analysis; P-values should be regarded only as a rough guide to the magnitude of differences between groups.

^cThis difference was statistically significant (P = .04); however, this was an exploratory analysis.